APA (7th ed.) Citation

WC, L., Y, S., J, L., & JL, P. (2012). Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: A CORE Diabetes Model analysis. Journal of medical economics, 15 Suppl 2, 28. https://doi.org/10.3111/13696998.2012.716111

Chicago Style (17th ed.) Citation

WC, Lee, Samyshkin Y, Langer J, and Palmer JL. "Long-term Clinical and Economic Outcomes Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes: A CORE Diabetes Model Analysis." Journal of Medical Economics 15 Suppl 2 (2012): 28. https://doi.org/10.3111/13696998.2012.716111.

MLA (9th ed.) Citation

WC, Lee, et al. "Long-term Clinical and Economic Outcomes Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes: A CORE Diabetes Model Analysis." Journal of Medical Economics, vol. 15 Suppl 2, 2012, p. 28, https://doi.org/10.3111/13696998.2012.716111.